Advertisement With this dual agonism, tirzepatide has demonstrated the largest weight loss in a randomized trial of any medication for obesity/overweight to date, with its highest dose achieving a 22.5% reduction relative to placebo at 72 weeks in the phase 3 SURMOUNT-1 trial ( N Engl J Med
We report a case in which the use of semaglutide for weight loss was associated with delayed gastric emptying and intraoperative pulmonary aspiration of gastric content
At the titrated once-daily doses, roughly one vial covers a 34 week phase at these once-daily doses, so plan several vials for a full course
Mazdutide leads in overall clinical evidence maturity with Phase 3 completion, regulatory approval, and head-to-head superiority data versus semaglutide
The docket rose from 3,658 cases in November 2025 to 3,749 cases in December 2025, resulting in 91 new filings